Clinical trial
Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I…
NCT00005821 · Royal Marsden NHS Foundation Trust, Other · Unknown status
Key facts
| NCT number | NCT00005821 |
|---|---|
| Title | Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer |
| Official title | Sentinel Lymph Node Biopsy in the Assessment of Axillary Nodal Status in Operable Breast Cancer |
| Lead sponsor | Royal Marsden NHS Foundation Trust, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | patent blue V dye, conventional surgery, lymphangiography, radionuclide imaging, sentinel lymph node biopsy, Technetium Tc 99m human serum albumin colloid |
| Start date | Dec 1, 1998 |
| First posted | Jan 27, 2003 |
| Last update posted | Nov 6, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: